Cromwell Holdings’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Buy
2,502
+246
+11% +$21.5K 0.1% 176
2026
Q1
$192K Buy
2,256
+1,322
+142% +$118K 0.11% 192
2025
Q4
$73.8K Buy
934
+520
+126% +$40.8K 0.04% 386
2025
Q3
$33.1K Sell
414
-842
-67% -$71.8K 0.02% 539
2025
Q2
$114K Sell
1,256
-1,084
-46% -$99K 0.07% 280
2025
Q1
$219K Sell
2,340
-262
-10% -$23.5K 0.14% 141
2024
Q4
$237K Hold
2,602
0.14% 132
2024
Q3
$270K Hold
2,602
0.17% 116
2024
Q2
$252K Buy
+2,602
New +$240K 0.15% 121

Other funds holding CL

Cromwell Holdings's CL Position: Q2 2026 in Review

Cromwell Holdings increased its Colgate-Palmolive (CL) stake by 11% in Q2 2026, buying an estimated $21.5K and bringing the position to 2,502 shares worth $229K. The position accounts for 0.1% of the portfolio, ranked #176.

Cromwell Holdings first reported a position in CL in Q2 2024 and has held it in 9 quarters since. The position peaked at $270K in Q3 2024. 339 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cromwell Holdings held 2,502 shares of Colgate-Palmolive worth $229K as of Q2 2026.
  • Cromwell Holdings bought 246 Colgate-Palmolive shares in Q2 2026, an estimated $21.5K.
  • Colgate-Palmolive made up 0.1% of Cromwell Holdings's portfolio in Q2 2026, its #176 holding.
  • Cromwell Holdings first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Colgate-Palmolive position peaked at $270K in Q3 2024.
  • 339 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.